Glucocorticoid Drugs Appear Effective At Treating Vaping Lung Injuries In Youths: Study

The findings of a new study suggests many individuals suffering from vaping lung disease may be effectively treated by taking steroids, which may provide guidance to medical providers looking to address the continuing outbreak, which has resulted in thousands of hospitalizations and dozens of deaths over the past year.

E-cigarette or vaping lung injury (EVALI) disease began to emerge in mid-2019, when doctors reported seeing a surge in patients, mostly teenagers and young adults, who were experiencing severe and potentially life-threatening respiratory problems after vaping.

The illnesses were first reported in Illinois and Wisconsin, and have since been linked to THC containing vaping products and products containing vitamin E acetate additives.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Recent estimates suggest that at least 60 deaths may be attributed to EVALI, and more than 3,000 individuals have been hospitalized nationwide. However, the true impact of the problems may be under-reported in recent months, since symptoms of the vaping lung injury may be similar to COVID-19.

In a study published in the July issue of the journal Pediatrics, researchers from Texas indicate that glucocorticoids helped treat 11 out of 12 patients who were affected by EVALI.

Researchers focused on a small group of 13 hospitalized teens who were diagnosed with confirmed or probable EVALI. A multidisciplinary committee developed an EVALI algorithm based on guidelines by the Centers of Disease Control and Prevention (CDC).

Overall, nearly 70% presented with respiratory symptoms and more than 85% suffered from gastrointestinal symptoms. More than 90% of patients reported using THC containing vape products while 62% of patients used e-cigarette products containing nicotine.

According to the findings, all patients had bilateral ground-glass opacities in the lungs found using chest computed tomography (CT) scans. However, treatment with glucocorticoids, a class of steroids, led to clinical improvement in 11 of 12 patients.

Patients experienced improved forced expiratory volume in one second, a measure of the ability to expel air from the lungs. This is a significant improvement considering the patients all experienced diminished or impaired respiratory function.

Forced vital capacity was also improved. This is a measure of lung function and can help doctors diagnose various lung diseases, including EVALI.

“Diagnosis of EVALI should be suspected on the basis of vaping history and clinical presentation,” wrote study authors. “Glucocorticoid treatment led to an improvement in symptoms and lung function.”

The researchers called for further evaluation of glucocorticoids as a treatment for many teenagers and young adults affected by vaping lung injuries.

Recently health officials called for stronger warnings to inform teens about the link between vaping THC products and lung injury risks, including EVALI. A recent study indicated more than 220 different brand names of THC containing e-cigarettes were linked to cases of recent vaping lung injury illnesses.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination
Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination (Posted today)

A group of 19 plaintiffs' lawyers have been appointed to serve in various leadership position during the consolidated pretrial proceedings for all baby food injury lawsuits, taking actions that benefit all families pursuing claims for children diagnosed with autism, ADHD or other developmental problems from toxic heavy metals found in many popular products sold in recent years.

Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024
Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024 (Posted 3 days ago)

A federal judge is allowing plaintiffs to file large numbers of Suboxone tooth decay lawsuits in one bundled complaint, to meet a potential two-year statute of limitations deadline, with the ability to flesh those claims out in more detail at a later date.